SEC Form 3 · accession 0001062993-15-002138
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jyrki Mattila
Director
Period of report
Apr 22, 2015
Accepted (ET)
Apr 23, 2015 · 6:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | holding | — | — | — | 376 | D |
Table II — derivative securities
No Table II lines on this filing.